India drops popular Zantac from essential medicine list over cancer concerns

India removes popular Zantac from essential medicine list due to cancer concerns

Tribune press service Aditi Tandon New Delhi, September 13 India on Tuesday removed the antacid Ranitidine, popularly sold as Zantac, from the National Essential Medicines List 2022 due to cancer concerns. Ranitidine is one of 26 drugs removed from the 2015 NLEM version. Zantac and other ranitidine products contaminated with high levels of NDMA, a …

India removes popular Zantac from essential medicine list due to cancer concerns Read More »